Chewy Inc vs iShares MSCI Singapore ETF — how do they compare? Chewy Inc trades at $22.38 (market cap $9.20B), while iShares MSCI Singapore ETF trades at $33.82. The key difference: iShares MSCI Singapore ETF is trading nearer its 52-week high, Chewy Inc nearer its low. Which is the better fit depends on your goals.
| CHWY | EWS | |
|---|---|---|
Market Cap | $9.20B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $42.33 | $33.92 |
52-Week Low | $17.51 | $26.71 |
Enterprise Value | $9.16B | — |
Signals from Pluang's Aura AI — not financial advice
CHWY trades at $22.38, down 0.93% on the day, with a bearish technical signal and neutral oscillators. Revenue grew to $11.86B in 2025, with net income surging to $392.74M, though margins remain thin. Recent news highlights insider selling and mixed institutional moves, while analyst consensus is strongly bullish with an $33.82 price target.
The stock offers growth potential from recurring revenue and market expansion but faces risks from competition and volatile earnings. With high valuation multiples and bearish technicals, near-term pressure may persist, but long-term prospects hinge on sustained profitability and execution against rivals like Amazon.
EWS, the iShares MSCI Singapore ETF, trades at $33.64, up 1.42% and hitting a new 52-week high. Technical indicators show a bullish moving average trend but overbought oscillators. The ETF benefits from Singapore's economic resilience, AI-driven growth, and a 3.97% dividend yield, with institutional interest rising as Amundi increased holdings by 4.8% in Q2 2026.
Outlook is positive due to strong momentum and structural growth in Singapore's financial and tech sectors. Risks include concentrated exposure to financials (54% of holdings) and sensitivity to Asian market volatility. The ETF offers diversification but requires monitoring for overextension near all-time highs.
Trailing returns across standard periods
Chewy is the largest e-commerce pet care retailer in the U.S., generating $8.9 billion in 2021 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a standalone company in 2019, after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.
Read more on CHWY →EWS tracks the MSCI Singapore 25/50 Index, providing targeted exposure to large and mid-cap companies in Singapore. It is heavily weighted toward the financial, industrial, and real estate sectors, serving as a liquid tool for accessing Singapore's stable, dividend-oriented developed economy.
Read more on EWS →